Literature DB >> 21533531

The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS.

Celia Patricia Kaplan1, Leah S Karliner, E Shelley Hwang, Joan Bloom, Susan Stewart, Dana Nickleach, Jessica Quinn, Angela Thrasher, Anna Maria Nápoles.   

Abstract

Treatment decisions associated with ductal carcinoma in situ (DCIS), including the decision to undergo breast reconstruction, may be more problematic for Latinas due to access and language issues. To help understand the factors that influence patients' receipt of reconstruction following mastectomy for DCIS, we conducted a population-based study of English- and Spanish-speaking Latina and non-Latina white women from 35 California counties. The objectives of this study were to identify the role of ethnicity and language in the receipt of reconstruction, the relationship between system-level factors and the receipt of reconstruction, and women's reasons for not undergoing reconstruction. Women aged 18 and older, who self-identified as Latina or non-Latino white and were diagnosed with DCIS between 2002 and 2005 were selected from eight California Cancer Registry (CCR) regions encompassing 35 counties. Approximately 24 months after diagnosis, they were surveyed about their DCIS treatment decisions. Survey data were merged with CCR records to obtain tumor and treatment data. The survey was successfully completed by 745 women, 239 of whom had a mastectomy and represent the sample included in this study. Whites had a higher completion rate than Latinas (67 and 55%, respectively). Analysis included descriptive statistics and logistic regression modeling. Mean age was 54 years. A greater proportion of whites had reconstruction (72%) compared to English-speaking Latinas (69%) and Spanish-speaking Latinas (40%). Multivariate analysis showed that women who were aged 65 and older, unemployed, and had a lower ratio of plastic surgeons in their county were less likely to have reconstructive surgery after mastectomy. The most frequent reasons mentioned not to receive reconstruction included lack of importance and desire to avoid additional surgery. Although ethnic/language differences in treatment selection were observed, multivariable analysis suggests that these differences could be explained by differential employment levels and geographic availability of plastic surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21533531      PMCID: PMC3684692          DOI: 10.1007/s10549-011-1524-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

Review 1.  Ductal carcinoma in situ of the breast.

Authors:  Harold J Burstein; Kornelia Polyak; Julia S Wong; Susan C Lester; Carolyn M Kaelin
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  Breast cancer treatment experiences of Latinas in Los Angeles County.

Authors:  Steven J Katz; Paula M Lantz; Yvonne Paredes; Nancy K Janz; Angela Fagerlin; Lihua Liu; Dennis Deapen
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

3.  Language barriers and patient-centered breast cancer care.

Authors:  Leah S Karliner; E Shelley Hwang; Dana Nickleach; Celia P Kaplan
Journal:  Patient Educ Couns       Date:  2010-08-03

4.  Correlates of breast reconstruction: results from a population-based study.

Authors:  Monica Morrow; Mahasin Mujahid; Paula M Lantz; Nancy K Janz; Angela Fagerlin; Kendra Schwartz; Lihua Liu; Dennis Deapen; Barbara Salem; Indu Lakhani; Steven J Katz
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

5.  Radiation therapy and patient age in the survival from early-stage breast cancer.

Authors:  S A Joslyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

6.  Patterns of care for immediate and early delayed breast reconstruction following mastectomy.

Authors:  Sue A Joslyn
Journal:  Plast Reconstr Surg       Date:  2005-04-15       Impact factor: 4.730

7.  Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database study.

Authors:  M Morrow; S K Scott; H R Menck; T A Mustoe; D P Winchester
Journal:  J Am Coll Surg       Date:  2001-01       Impact factor: 6.113

8.  The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.

Authors:  Jennifer F Tseng; Steven J Kronowitz; Charlotte C Sun; Allison C Perry; Kelly K Hunt; Gildy V Babiera; Lisa A Newman; S Eva Singletary; Nadeem Q Mirza; Frederick C Ames; Funda Meric-Bernstam; Merrick I Ross; Barry W Feig; Geoffrey L Robb; Henry M Kuerer
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

9.  The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors.

Authors:  Amy K Alderman; Laurence McMahon; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2003-02       Impact factor: 4.730

10.  Trends in the treatment of ductal carcinoma in situ of the breast.

Authors:  Nancy N Baxter; Beth A Virnig; Sara B Durham; Todd M Tuttle
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

View more
  3 in total

1.  Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS.

Authors:  Mónica E López; Celia P Kaplan; Anna M Nápoles; E Shelley Hwang; Jennifer C Livaudais; Leah S Karliner
Journal:  Patient Educ Couns       Date:  2013-09-17

2.  Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making.

Authors:  Monica Morrow; Yun Li; Amy K Alderman; Reshma Jagsi; Ann S Hamilton; John J Graff; Sarah T Hawley; Steven J Katz
Journal:  JAMA Surg       Date:  2014-10       Impact factor: 14.766

3.  The Impact of Travel Distance on Breast Reconstruction in the United States.

Authors:  Claudia R Albornoz; Wess A Cohen; Shantanu N Razdan; Babak J Mehrara; Colleen M McCarthy; Joseph J Disa; Joseph H Dayan; Andrea L Pusic; Peter G Cordeiro; Evan Matros
Journal:  Plast Reconstr Surg       Date:  2016-01       Impact factor: 4.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.